In Vitro Diagnostic (IVD) Reagents Market to Reach $77.6 Billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis and Forecasts by Meticulous Research®

Meticulous Research®– leading global market research company published a research report titled “In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) – Global Forecast to 2027”.

According to this latest publication from Meticulous Research®, the IVD reagents market is expected to grow at a CAGR of 7% from 2020 to reach $77.6 billion by 2027. The high growth of the IVD reagents market is mainly attributed to the factors such as increasing global prevalence of acute and chronic infectious diseases coupled with rising geriatric population, increasing adoption of flow cytometry techniques in research and academia, increase in funding for research activities, and rising proteomics and genomics research studies. Moreover, the growing demand for protein therapeutics and personalized medicines and emerging economies offer significant growth opportunities for the players operating in this market. However, the unfavorable restrictions on approval procedure is expected to hamper the growth of the IVD reagents market to some extent.

Download Free PDF Sample Copy of the Report (with covid 19 Impact Analysis): https://www.meticulousresearch.com/download-sample-report/cp_id=5110

We provide crucial, accurate, and real time market data that helps these executives to take informed decisions and deliver maximum impact. We provide Research That Revolutionizes Your Business.

The global IVD reagents market study presents historical market data in terms of values (2018 and 2019), estimated current data (2020), and forecasts for 2027- by type (oligonucleotide, antibodies, nucleic acid probe), technology (immunoassay, hematology, microbiology), use (research, analyte specific reagent), end user (IVD manufacturer, clinical laboratory), and geography. The study also evaluates industry competitors and analyzes the market at a country level.

Any Question | Speak to Analyst : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5110

Scope of the Report:

IVD Reagents Market, by Technology

Immunoassay/Immunochemistry
Enzyme-Linked Immunosorbent Assays (Elisa)
Western Blotting
Immunofluorescence
Immunohistochemistry
Functional Assays
Immunoprecipitation
Other Technologies
Biochemistry/Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation/Hemostatis
Urinalysis
Other Technologies
(Other Technologies comprises of hybridization and loop-mediated isothermal amplification among others)

IVD Reagents Market, by Type

Antibodies
Antibodies Market, By Type
Monoclonal
Polyclonal

Antibodies Market, By Target
CD
TCR
EGFR
Other Targets
Oligonucleotides
Nucleic Acid Probes
Purified Proteins or Peptides
Other Reagents
(Other reagents include Blocking Agents, Detergents, Surfactants, Wetting Agents, Buffers, Stabilizers, Purified Water, Dyes, Standards & Controls, Enzymes, Cell Culture Reagents, and Anti-coagulants)

IVD Reagents Market, by Use

Research Use Only
Analyte Specific Reagents
Clinical Use

IVD Reagents Market, by End User

IVD Manufacturers
Reference Laboratories
Academic and Research Institutes
Hospital Laboratories

IVD Reagents Market, by Geography

North America
U.S.
Canada
Europe
Germany
Italy
France
U.K.
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of Asia Pacific (RoAPAC)
Latin America
Middle East & Africa

Get the PDF to understand the CORONA Virus/COVID19 impact and be smart in redefining business strategies: https://www.meticulousresearch.com/request-sample-report/cp_id=5110

Based on type, the antibodies segment is estimated to hold the largest share of the overall IVD reagents market in 2020. However, the oligonucleotides segment is expected to grow at the fastest CAGR during the forecast period. The fast growth of this segment is mainly attributed to the factors such as advancements in the field of genomics research, growing adoption of custom oligonucleotides, and rising strategic developments such as agreements and collaborations to expand oligonucleotides market.

Based on use, the research use segment is estimated to hold the largest share of the overall IVD reagents market in 2020. However, the clinical use segment is expected to grow with the fastest CAGR during the forecast period, mainly due to the factors such as rising adoption of advanced diagnostic modalities, growing importance of early disease diagnosis, number of diagnostic product launches, and demand for innovative reagents and assays for clinical usage.

Based on end user, the IVD manufacturers segment is estimated to command the largest share of the overall IVD reagents market in 2020. The factors such as rising number of research activities for the development of innovative IVDs, growing public and private funds, and rising demand for advanced disease diagnostics are expected to drive the growth of the IVD reagents market for IVD manufacturing during the forecast period. Moreover, the recent outbreak of COVID-19 is also expected to support the growth of the IVD reagents market for this segment. However, the clinical laboratories segment is expected to register the highest growth during the forecast period.

Purchase This Report (Price 3757 USD for single user license): https://www.meticulousresearch.com/Checkout/21348226

Geographic Review:

This research report analyzes major geographies and provides comprehensive analysis for North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is estimated to dominate the global IVD reagents market in 2020, followed by Europe and Asia Pacific. The factors such as growing healthcare sector, increasing need to treat various infectious diseases in early stage, increasing healthcare expenditure, and growing investments in personalized medicine and development of novel advanced technologies for diagnosis are supporting the largest share of North America in the global IVD reagents market.

Key Players:

The key players operating in the overall IVD reagents market are Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), LGC Biosearch Technologies (U.K.), BioLegend, Inc. (U.S.), InBios International, Inc. (U.S.), LakePharma, Inc. (U.S.), Bioline (U.K.), Abcam plc (U.K.), The Binding Site Group Ltd.(U.K.), SDIX, LLC (U.S.), DIACLONE SAS (France), Bio-Techne Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Hologic Inc. (U.S.), Bio-Synthesis Inc. (U.S.), RayBiotech, Inc. (U.S.), and Sino Biological Inc. (China), among others.

Enquire Here for, Report Enquire, Discount and Customization: https://www.meticulousresearch.com/enquire-before-buying/cp_id=5110

Key questions answered in the report-

What is the current value of revenue generated by the IVD reagents across the globe?
At what rate the demand for IVD reagents is projected to grow for the next 5-7 years?
What is the historical market size and growth rate for IVD reagents across the globe?
What are the major factors impacting the growth of this market at global and regional level? What are the major opportunities for existing market players and new entrants in the market?
What impact does the current COVID-19 pandemic have on the IVD reagents market at various levels in the value chain?
Which segments in terms of the type, use, technology, and end user are creating the major traction for the vendors in this market?
What are the key geographical trends in this market? Which regions/countries are expected offer significant growth opportunities for the vendors operating in IVD reagents market?
Who are the major players in the global IVD reagents market? And also, what are their specific product offerings in the IVD reagents industry?
What recent developments have taken place in the global IVD reagents market?
Related Report:

In-vitro Diagnostics Market by Product & Solution (Consumables, Systems, Software & Services), Technology (ELISA, Rapid Tests, PCR, Microbiology), Application (Infectious Diseases, Oncology), End User (Hospitals, Diagnostic Laboratories) – Forecast to 2027
https://www.meticulousresearch.com/product/ivd-market-4858

Latin America In Vitro Diagnostics (IVD) Market by Product (Consumables, Instruments, Software), Technology (Immunoassay, Microbiology, Molecular Diagnostics), Application (Oncology, Diabetes), End User (Hospital, Reference Lab) – Forecast to 2027

https://www.meticulousresearch.com/product/latin-america-in-vitro-diagnostics-IVD-market-5105

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Asia-Pacific
Office No-202, 203,204,205,206;
2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad,
411057, India.

Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

This release was published on openPR.